Cargando…

The phenotypic presentation of adult individuals with SLC6A1-related neurodevelopmental disorders

INTRODUCTION: SLC6A1 is one of the most common monogenic causes of epilepsy and is a well-established cause of neurodevelopmental disorders. SLC6A1-neurodevelopmental disorders have a consistent phenotype of mild to severe intellectual disability (ID), epilepsy, language delay and behavioral disorde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johannesen, Katrine M., Nielsen, Jimmi, Sabers, Anne, Isidor, Bertrand, Kattentidt-Mouravieva, Anja A., Zieglgänsberger, Dominik, Heidlebaugh, Alexis R., Oetjens, Kathryn F., Vidal, Anna Abuli, Christensen, Jakob, Tiller, Jacob, Freed, Amber N., Møller, Rikke S., Rubboli, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472133/ https://www.ncbi.nlm.nih.gov/pubmed/37662110 http://dx.doi.org/10.3389/fnins.2023.1216653

Ejemplares similares

Intrafamilial variability in SLC6A1-related neurodevelopmental disorders
por: Kassabian, Benedetta, et al.
Publicado: (2023)

Corrigendum: Intrafamilial variability in SLC6A1-related neurodevelopmental disorders
por: Kassabian, Benedetta, et al.
Publicado: (2023)

Editorial: SLC6A1: the past, present and future
por: Johannesen, Katrine M., et al.
Publicado: (2023)

Current knowledge of SLC6A1-related neurodevelopmental disorders
por: Goodspeed, Kimberly, et al.
Publicado: (2020)

SLC6A1 variant pathogenicity, molecular function and phenotype: a genetic and clinical analysis
por: Stefanski, Arthur, et al.
Publicado: (2023)

Population Genomic Screening for Genetic Etiologies of Neurodevelopmental/Psychiatric Disorders Demonstrates Personal Utility and Positive Participant Responses
por: Wain, Karen E., et al.
Publicado: (2021)

A draft conceptual model of SLC6A1 neurodevelopmental disorder
por: Goodspeed, Kimberly, et al.
Publicado: (2023)

Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss‐of‐function variant
por: Gjerulfsen, Cathrine E., et al.
Publicado: (2023)

Epilepsy Syndromes in the First Year of Life and Usefulness of Genetic Testing for Precision Therapy
por: Bayat, Allan, et al.
Publicado: (2021)

Duplications at 19q13.33 in patients with neurodevelopmental disorders
por: Pérez-Palma, Eduardo, et al.
Publicado: (2018)

Neurodevelopmental phenotypes in individuals with pathogenic variants in CHAMP1
por: Garrity, Madison, et al.
Publicado: (2021)

CNVs in neurodevelopmental disorders
por: Lee, Chun-Ting, et al.
Publicado: (2015)

SLC35F1 as a candidate gene for neurodevelopmental disorders resembling Rett syndrome
por: Di Fede, Elisabetta, et al.
Publicado: (2021)

Morphological and behavioral analysis of Slc35f1-deficient mice revealed no neurodevelopmental phenotype
por: Ehlers, Julia Sophie, et al.
Publicado: (2023)

Expanding the phenotype of HNRNPU ‐related neurodevelopmental disorder with emphasis on seizure phenotype and review of literature
por: Taylor, James, et al.
Publicado: (2022)

T10. BIOMARKERS IN TREATMENT-RESISTANT SCHIZOPHRENIA; THE BITS STUDY (A STUDY PROTOCOL)
por: Hilker, Rikke, et al.
Publicado: (2020)

424 Clinical Translational Approach to Targeted Therapy in SLC6A1-related Neurodevelopmental Disorder
por: Goodspeed, Kimberly, et al.
Publicado: (2023)

Functional and structural analyses of novel Smith-Kingsmore Syndrome-Associated MTOR variants reveal potential new mechanisms and predictors of pathogenicity
por: Besterman, Aaron D., et al.
Publicado: (2021)

Health, well-being and social relations in a changing neighbourhood: protocol for a prospective, multimethods study of the consequences of large structural changes in an ethnic diverse social housing area in Denmark
por: Lund, Rikke, et al.
Publicado: (2019)

Substance P and pain chronicity
por: Zieglgänsberger, W.
Publicado: (2018)

Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder
por: Kalvakuntla, Sanjana, et al.
Publicado: (2023)

MED27, SLC6A7, and MPPE1 Variants in a Complex Neurodevelopmental Disorder with Severe Dystonia
por: Reid, Kimberley M., et al.
Publicado: (2022)

Estimating the effect size of the 15Q11.2 BP1–BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice
por: Jønch, Aia Elise, et al.
Publicado: (2019)

Two de novo GluN2B mutations affect multiple NMDAR-functions and instigate severe pediatric encephalopathy
por: Kellner, Shai, et al.
Publicado: (2021)

DNA Methylation Signature for JARID2-Neurodevelopmental Syndrome
por: Verberne, Eline A., et al.
Publicado: (2022)

A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants
por: López-Rivera, Javier A, et al.
Publicado: (2020)

Lemierre’s syndrome: current perspectives on diagnosis and management
por: Johannesen, Katrine M, et al.
Publicado: (2016)

Spotlight on Asteroid Hyalosis: A Clinical Perspective
por: Scott, Daniel Andrew Richard, et al.
Publicado: (2021)

Na(+) dependent acid-base transporters in the choroid plexus; insights from slc4 and slc9 gene deletion studies
por: Christensen, Henriette L., et al.
Publicado: (2013)

A prospective observational longitudinal study of new-onset seizures and newly diagnosed epilepsy in dogs
por: Fredsø, N., et al.
Publicado: (2017)

SLC-2000: a luminosity upgrade for the SLC
por: Breidenbach, M, et al.
Publicado: (1996)

Deep-Phenotyping the Less Severe Spectrum of PIGT Deficiency and Linking the Gene to Myoclonic Atonic Seizures
por: Bayat, Allan, et al.
Publicado: (2021)

Mental Health Staff’s Perspectives on Tapering of Antipsychotic Medication: A Focus Group Study
por: Roed, Kickan, et al.
Publicado: (2023)

The fraction of activated N-methyl-d-Aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole
por: Rammes, G., et al.
Publicado: (2008)

Resolution of Ultramicroscopy and Field of View Analysis
por: Leischner, Ulrich, et al.
Publicado: (2009)

Effects of Childhood Multidisciplinary Care and Growth Hormone Treatment on Health Problems in Adults with Prader-Willi Syndrome
por: Pellikaan, Karlijn, et al.
Publicado: (2021)

Bad news itself or just the messenger? The high mortality of Fusobacterium spp. infections is related to disseminated malignancy and other comorbidities
por: Johannesen, Katrine, et al.
Publicado: (2016)

Status of the SLC
por: Seeman, J T, et al.
Publicado: (1987)

Polarization at SLC
por: Swartz, M L
Publicado: (1988)

The Prognostic Value of Pain Phenotyping in Relation to Treatment Outcomes in Patients with Axial Spondyloarthritis Treated in Clinical Practice: A Prospective Cohort Study
por: Andreasen, Rikke Asmussen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_07ckqrtjs0oh36f3oh28nrb38g